FEB 23, 2020 7:33 PM PST

Celular aging reexamined

New research published in Genes and Development has identified one of the mysteries of aging. According to scientists at Sanford Burnham Prebys Medical Discovery Institute and Harvard University, mitochondria trigger senescence. Senescence refers to the sleep-like state of aged cells.

In addition to this discovery, the recent study also reports that an already FDA-approved drug could suppress senescence, which has significant implications for diseases related to aging such as cancer, Alzheimer's disease, heart disease, among others.

Senior author Peter Adams, Ph.D., is a professor in Sanford Burnham Prebys' National Cancer Institute (NCI)-designated Cancer Center. He commented, "Our findings provide a foundation upon which we can start to develop drugs that extend our health span -- the number of years we live a healthy life. Given the major social and economic hurdles we will soon face as millions of Americans grow older, interventions can't come soon enough."

In conducting their study, the researchers modeled senescence in human lung cells. They were able to identify mitochondria as the driver of certain inflammatory signals through its communication with the nucleus. Such inflammatory responses are associated with several negative health effects.

"In school we learned that the role of mitochondria is to generate energy -- and that DNA controls everything the cell does," explains Adams. "Research is now showing that mitochondria are important sensors for the cell and have a lot of cross-talk with the nucleus, which makes sense given their duty to respond to the cell's metabolic needs."

Photo: Pixabay

Furthermore, the team showed that an HDAC inhibitor drug that is currently used to treat some cancers is capable of suppressing senescence by changing cells’ shapes. Interestingly, the scientists observed that senescent cells administered the drug generated fewer inflammatory signals. They hope to continue investigating senescence-inhibiting drugs at the Institute's Conrad Prebys Center for Chemical Genomics.

"This study provides the first concrete link between several known hallmarks of aging -- dysfunctional mitochondria, inflammation, and senescent cells -- which historically were studied as separate events," says Adams. "We are hopeful that targeting the molecular drivers of senescence will lead us to safe and effective medicines that help more people stay as healthy as possible, for as long as possible."

Sources: Genes and Development, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 21, 2020
Cell & Molecular Biology
JAN 21, 2020
Repurposing Existing Drugs to Treat Cancer
Drugs have to be rigorously tested before they can be offered to patients, so it can be much easier to find more than one application for a medication....
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Acid-Reflux Drugs May Negatively Impact Breast Cancer Survivors
Many of us have taken some form of an acid-reflux drug—especially after a meal that causes discomfort. However, now researchers are indicating that s...
FEB 10, 2020
Cancer
FEB 10, 2020
New hope for KRAS-mutant pancreatic cancers
A study published recently in the journal Cancer Research showcases the findings from new research on pancreatic cancer. The study was led by Frank Mc...
FEB 19, 2020
Immunology
FEB 19, 2020
Testing the Immune Response to Ovarian Cancer Treatment
There is a new diagnostic test for the deadliest form of gynecological cancer – ovarian cancer. Better tests mean better diagnostics, and better diag...
FEB 19, 2020
Technology
FEB 19, 2020
Novel Technology Analyzes Single Cancer Cells
Recent technology may help for the first time to enable cancer scientists the analysis of individual behavior of millions of different cells living inside ...
MAR 21, 2020
Cancer
MAR 21, 2020
Identifying aggressive prostate cancer subtypes
New research published yesterday in the British Journal of Cancer from scientists at the University of East Anglia describes what makes certain prostate ca...
Loading Comments...